Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.
FATE THERAPEUTICS, INC. and WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH |
SHORELINE BIOSCIENCES, INC. |
24-1055 |
October 17, 2023 |
U.S. Court of Appeals, Federal Circuit |
Patent Infringement (Fed. Qst.) |
Docket Report
This docket was last retrieved on October 17, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 2 Note to File: The following cases are consolidated: 24-1021 Lead with 24-1055 Cross-Appeal. The parties must file all documents in the lead appeal only. [957030] [24-1021, 24-1055] [KMH] [Entered: 10/17/2023 03:02 PM] |
Filing 1 Appeal docketed. Received: 10/11/2023. [957027] Entry of Appearance due 10/31/2023. Certificate of Interest is due on 10/31/2023. Docketing Statement due 10/31/2023. Appellant/Petitioner's brief is due 12/18/2023. [KMH] [Entered: 10/17/2023 02:58 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.